Phase I/II dose escalation trial of patupilone every 3 weeks in patients with non-small cell lung cancer.

被引：0
|
作者：
Osterlind, K
Sánchez, JM
Zatloukal, P
Hamm, J
Belani, CP
Kim, E
Felip, E
Johri, A
Berton, M
Sklenar, I
机构：
[1] Herlev Univ Hosp, DK-2730 Herlev, Denmark
[2] Hosp Germans Trias & Pujol, Barcelona, Spain
[3] Univ Hosp Na Bulovce, Prague, Czech Republic
[4] Norton Healthcare Hosp Inc, Louisville, KY USA
[5] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[6] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] Vall Hebron Univ Hosp, Barcelona, Spain
[8] Novartis Pharmaceut Corp, E Hanover, NJ USA
[9] Novartis Pharma AG, Basel, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：647S / 647S
页数：1
相关论文
共 50 条
  • [31] Phase I/II study of amrubicin and nedaplatin in patients with untreated, advanced non-small cell lung cancer.
    Senju, Hiroaki
    Ogawara, Daiki
    Nakamura, Yoichi
    Fukuda, Minoru
    Nakatomi, Katsumi
    Gyotoku, Hiroshi
    Nakano, Hirofumi
    Yamaguchi, Hiroyuki
    Tomonaga, Nanae
    Ikeda, Takaya
    Mizoguchi, Kosuke
    Motoshima, Kohei
    Doi, Seiji
    Tsukamoto, Kazuhiro
    Kohno, Shigeru
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [32] ACTIVITY OF PATUPILONE IN ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE II STUDY
    Zatloukal, P.
    Mellemgaard, A.
    Sanchez, J. M.
    Perry, M. C.
    Hamm, J. T.
    Van Meerbeeck, J.
    DeLeo, J. J.
    Gao, B.
    Johri, A. R.
    Felip, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 109 - 109
  • [33] Phase I/II Dose Escalation Study of L-DOS47 as a Monotherapy in Non-Squamous Non-Small Cell Lung Cancer Patients
    Ramlau, Rodryg
    Kowalski, Dariusz
    Szczylik, Cezary
    Szczegsna, Aleksandra
    Wiatr, Elzbieta
    Demas, Steve
    Chao, Heman
    Roszkowski-Sliz, Kazimierz
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1071 - S1072
  • [34] Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non-Small Cell Lung Cancer: A Phase I Dose Escalation Study
    Pujol, Jean-Louis
    De Pas, Tommaso
    Rittmeyer, Achim
    Vallieres, Eric
    Kubisa, Bartosz
    Levchenko, Eugeny
    Wiesemann, Sebastian
    Masters, Gregory A.
    Shen, Robert
    Tjulandin, Sergei A.
    Hofmann, Hans-Stefan
    Vanhoutte, Nicolas
    Salaun, Bruno
    Debois, Muriel
    Jarnjak, Silvija
    Alves, Pedro Miguel De Sousa
    Louahed, Jamila
    Brichard, Vincent G.
    Lehmann, Frederic F.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (12) : 2208 - 2217
  • [35] Prospectively scored pulmonary toxicities in non-small cell lung cancer: Results from a randomized phase II dose escalation trial
    Lutz, Christina M.
    Knap, Marianne M.
    Hoffmann, Lone
    Moller, Ditte S.
    Hansen, Olfred
    Brink, Carsten
    Schytte, Tine
    Nyhus, Christa H.
    McCulloch, Tine
    Borissova, Svetlana
    Alber, Markus
    Khalil, Azza A.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2021, 27 : 8 - 14
  • [36] Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer
    Masters, GA
    Hahn, EA
    Shevrin, DH
    Kies, MS
    LUNG CANCER, 2003, 39 (02) : 221 - 226
  • [37] Phase I trial of nedaplatin and paclitaxel for patients with non-small cell lung cancer
    Yoshiike, F
    Koizumi, T
    Kitaguchi, Y
    Hatayama, O
    Yasuo, M
    Sasabayashi, M
    Wakamatsu, H
    Fujimoto, K
    Kubo, K
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (05) : 550 - 554
  • [38] IDEAL CRT: ISOTOXIC DOSE ESCALATION AND ACCELERATION IN LUNG CANCER CHEMORADIOTHERAPY - A PHASE I/II TRIAL OF CONCURRENT CHEMORADIATION WITH DOSE-ESCALATED RADIOTHERAPY IN PATIENTS WITH STAGE II OR STAGE III NON-SMALL CELL LUNG CANCER
    Landau, David B.
    Khan, Iftekhar
    Ngai, Yenting
    Hughes, Laura L.
    Miles, Elizabeth
    Wilkinson, Dean
    Parsons, Emma
    Mayles, Philip
    Mayles, Helen
    Bates, Andrew T.
    Mohammed, Nazia
    Hicks, Jonathan
    Harden, Susan
    Illsley, Marianne
    Garcia, Angel
    Malik, Zafar
    Hughes, Simon
    Spicer, James
    Baker, Angela
    Wells, Paula
    Laurence, Virginia
    Fenwick, John
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S190 - S190
  • [39] Risk Factors for the Recurrence in Patients with Stage I and II Non-Small Cell Lung Cancer.
    Park, I. W.
    Cho, S. G.
    Kang, H. G.
    Lee, H. M.
    Kwak, H. W.
    Chung, J. W.
    Choi, J. C.
    Shin, J. W.
    Kim, J. Y.
    Choi, B. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [40] Phase I/II trial of paclitaxel and vinorelbine in advanced non-small cell lung cancer
    Grunberg, SM
    Dugan, MC
    Greenblatt, MS
    Ospina, DJ
    Valentine, JW
    CANCER INVESTIGATION, 2005, 23 (05) : 392 - 398
12345